Patients with diabetic retinopathy (DR) or diabetic macular edema (DME) tend to have a host of comorbidities and a considerable burden of required treatments and medical appointments. Recent additions to treatment options for DR and DME provide opportunities to reduce...

This online, on-demand virtual symposium brings together renowned experts on Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available therapies. This educational activity is an archive of the...

Providing early diagnosis and patient-centered treatment for neurotrophic keratitis (NK)—a condition that results from disrupted corneal innervation—can pose challenges. Management of NK requires the identification of symptoms that may be subtle and an understanding of the factors underlying each patient’s...

This video-based program is designed for eye care professionals to explore the management of neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) using newer anti-VEGF agents with the potential for extended treatment intervals. This program places the patient’s...

This online, on-demand virtual symposium brings together renowned experts in neurotrophic keratitis (NK). In this educational program, these experts discuss the symptoms associated with NK, present video demonstrations of various techniques for corneal sensitivity testing, and share their perspectives and...

This online, on-demand virtual symposium brings together renowned experts in Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available and investigational therapies. This educational activity is an archive...

Although anti-VEGF therapies have advanced the management of nAMD and DME, limitations with their use – including the need for frequent injections – led to the development of newer anti-VEGF agents. In this program, a panel of expert faculty share...

With recent additions to treatment options for neovascular age-related macular degeneration (nAMD) come new questions. How can newer anti-VEGF therapies affect the treatment burden for patients with nAMD? Which patients can attain longer treatment intervals, and what are the criteria...

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding management of this disorder, share their perspectives and best practices,...

This online, on-demand virtual symposium brings together experts in dry eye disease (DED). In this educational program, these experts share insights into recent neuromodulation opportunities in DED, as well as emerging mechanisms of action, such as targeting TRPM8 thermoreceptors to...